Molecular mechanic and monte carlo study of polymorphism effects on biophysical chemistry properties of XRCC1 BRCT2 domain
Bork P, Hofmann K, Koonin EV, Bucher P, Neuwald AF, Altschul SF. 1997. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. Federation of American Societies for Experimental Biology 11(1), 68–76.
Caldecott KW. 2001. Mammalian DNA single-strand break repair: an X-ra(y) ted affair. BioEssays 23, 447-455.
Caldecott KW. 2003. XRCC1 and DNA strand break repair. DNA Repair (Amst) 2(9), 955-969.
Caldecottn KW, McKeown CK, Tucker JD, Ljungquist S, Thompson LH. 1994. An interaction between the mammalian.DNA repair protein XRCC1 and DNA ligase III. Molecular Cell Biology 14, 68–76.
Camilla FS, Mona S, Håkan W, Bjørn AN, Per CH, Inger M, Bowitz L, Steinar A, Egil J, Inger-Lise H, Ulla V, Elin HK. 2006. Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. Biomedical central cancer 6, 67.
Chih-Ching Y, Fung-Chang S, Reiping T, Chung RC, Ling-Ling H. 2005. Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. Biomedical central cancer 5, 12.
Clarkson SG, Wood RD. 2005. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair (Amst) 4, 1068–1074.
Dai L, Duan F, Wang P, Song C, Wang K, Zhang J. 2012. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Molecular Biology Reports 1(3), 11-16.
Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, Mark EJ, Wain JC, Christiani DC, Kelsey KT. 2000. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood monounclear cells.Carcinogenesis 21, 965-971.
Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS. 2004. Christiani DC: XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treatment with platinum chemotherapy. Journal of Clinical Oncology 22, 2594-2601.
Hayden PJ, Tewari P, Morris DW, Staines A, Crowley D, Nieters A, Becker N, de Sanjose S, Foretova L, Maynadie M. 2007. Variation in DNA repairs genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Human Molecular Genetics 16, 3117–3127.
Kubota Y, and Horiuchi S. 2003. Independent roles of XRCC1’s two BRCTmotifs in recovery from methylation damage. DNA Repair (Amst) 2, 407–415.
Lodish H, Berk A, Matsudaira P, Kaiser CA, Krieger M, Scott MP, Zipursky SL, Darnell J. 2004. Molecular Biology of the Cell, p963. WH Freeman: New York, NY. 5th ed.
Paul AL, Matthew JC, Geoffrey AM, Eugene FD, Scott AG, Robert E. 2011. Structural studies of the PARP-1 BRCT domain. BMC Structural Biology 11, 37
Richard M. Taylor, Angela Thistlethwaite, Keith W. 2002. Caldecott. Central Role for the XRCC1 BRCT I Domain in Mammalian DNA Single- Strand Break Repair. Molecular Cell Biology 22(8), 2556-2563
Stoehlmacher J, Ghaderi V, Iobal S, Groshen S, Tsao-Wei D, Park D, Lenz HJ. 2001. A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer 21, 3075-3079.
Taylor M, Wickstead C, Adecott W. 1998. Role of a BRCT domain in the interaction of DNA ligase III-alpha with the DNA repair protein XRCC1. Current Biology 8, 77–880.
Weiner S, Kollman P, Case D, 1984. A new force field for molecular mechanical simulation of nucleic acids and proteins. Journal of the American Chemical Society 106, 765-84.
Xiaodong Z, Solange M, Paul A. Bates, Philip C, Coffer, Karl H, Rachel A. Nash, Michael JE. 1998. Structure of an XRCC1 BRCT domain: a new protein–protein interaction module. The Embo Journal 17, 6404 – 6411
Zhang L, Ruan Z, Hong Q, Gong X, Hu Z, Huang Y, Xu A. 2012. Single nucleotide polymorphisms in DNA repair genes and risk of cervical cancer: A case-control study. Oncology Letters 3(2), 351-362.
Zhanna K, Svetlana N, Olga I, Lavrik J, Pablo R. 2006. XRCC1 interactions with base excision repair DNA intermediates.21, 3-8.